In contrast, tumor-derived soluble factors M-CSF, IL-6, IL-1β, IL-4, IL-10, CCL2 initiate the immunosuppressive pathways that commit immature myeloid cells to become MDSCs and further promote the differentiation towards M-MDSC (30, 32). Here, CCL2 is linked to neoplasm.